go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Abbott Laboratories Ireland Limited
4051 Kingswood Drive, Citywest Business Campus, Dublin 24,
Telephone: +353 1 469 1500
Fax: +353 1 469 1501
Patient Information Leaflet last updated on medicines.ie: 01/07/2011
PIL Humira 40mg solution for injection in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 01/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to dosage and administration
Updated on 18/02/2011 and displayed until 01/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/10/2010 and displayed until 18/02/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 21/06/2010 and displayed until 08/10/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/06/2010 and displayed until 21/06/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 10/08/2009 and displayed until 01/06/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/05/2009 and displayed until 10/08/2009
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 13/03/2009 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 10/10/2008 and displayed until 13/03/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to information about driving or using machinery
Updated on 16/01/2008 and displayed until 10/10/2008
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 24/07/2007 and displayed until 16/01/2008
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 25/04/2007 and displayed until 24/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 29/11/2006 and displayed until 25/04/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  adalimumab